DVT and PE (pulmonary embolism)- What is it? & the plastic surgery risks

Links shared publicly online about this topic.

  • 859
    total visits

DVT and PE (pulmonary embolism)- What is it? & the plastic surgery risks

laurengreenbergmd.com

Surgery has risks. Cosmetic elective surgery needs to be as safe as we can make it. It is elective. Most of my patients are moms. Are you at risk? DVT

View full resource at laurengreenbergmd.com

Tags: Circulatory Disorders, Deep Venous Thrombosis, Thrombotic Event, Cosmetic Procedure, Plastic Surgery, Pulmonology, Surgery

  • Share

Most Recently Shared on September 20, 2010 at 8:16 pm By:

LGreenbergMD Lauren Greenberg

DVT and PE (pulmonary embolism)- What is it? & the plastic surgery risks http://tinyurl.com/28sp9e8

2 years ago...

What's In Your Stocking? Make Sure It's Not DVT

medicalnewstoday.com — “Deep vein thrombosis (DVT) is a blood clot in the deep veins in the legs. These clots can break loose and travel to the lungs, causing a potentially fatal pulmonary embolism (PE). Even when they dView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on December 9, 2011 at 10:07 am By:

Deep Venous Thrombosis and Thrombophlebitis: eMedicine Emergency Medicine

emedicine.medscape.com — “Overview: Deep venous thrombosis (DVT) and its sequela, pulmonary embolism (PE), are the leading causes of preventable in-hospital mortality in the United States. Although PE itself is discussed in other articles, it occurs primarily as a complication ...View full resource at emedicine.medscape.com

  • View Related
  • Share

Most Recently Shared on April 23, 2010 at 3:50 am By:

Health_SS Susan S Health Advocate

Deep venous thrombosis and thrombophlebitis can cause medical emergencies. Learn more about these conditions. http://bit.ly/9uaNXS

2 years ago...

Daiichi Sankyo initiates Phase III trial of edoxaban in reducing recurrent VTE complications

news-medical.net — “Daiichi Sankyo Company, Limited, announced today that it has initiated a new large-scale pivotal Phase III trial for edoxaban, its investigational oral Factor Xa inhibitor. This new study, called HOKUSAI (pronounced hoe·koo·sigh) VTE, is evaluating the safety and efficacy of edoxaban in reducing recurrent venous thromboembolic (VTE) complications in patients with deep vein thrombosis (DVT) and/or pulmonary embolism (PE).View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on February 4, 2010 at 6:51 am By:

Stroke_News News-Medical.Net Health News

Stroke News: Daiichi Sankyo initiates Phase III trial of edoxaban in reducing recurrent VTE complications: Daiic... http://twurl.nl/k3j5mw

2 years ago...

Rosuvastatin in the prevention of venous thromboembolism

blogs.theheart.org — “A landmark megatrial cuts the rate of DVT and pulmonary embolism by more than 40%, without any increased risk of bleeding. The JUPITER Trial releases its landmark findings in DVT and PE prevention.View full resource at blogs.theheart.org

  • View Related
  • Share

Most Recently Shared on May 29, 2009 at 4:01 pm By:

Heartfelt_Blog Dr Walton-Shirley Internist, Cardiologist, Physician, and Doctor

Rosuvastatin in the Prevention of Venous Thromboembolism: What are the implication of the JUPITER trial's landma.. http://bit.ly/Xf49m

3 years ago...

Advertisement